ARCHIVES

Results With New Agents, New Approaches Highlighted At ASCO Annual Meeting

This article is from The Cancer Letter archive.

Vol. 33 No. 6 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

December Business & Regulatory Report included in this issue.

December 12, 2003

Also in this 8-page issue: The Cancer Letter wins two awards for its “authoritative examination” of NCI.

June 11, 2004

ODAC Recommends Approval of Gemcitabine For Pancreatic Cancer

August 4, 1995

5-FU/Levamisole A community Success Story; Trials With Untreated Control Revised Or Dropped

October 13, 1989

AACI Remains Split On Guidelines; Terry Proposes 25 Percent Limit On Staff Investigator Salaries

January 30, 1981

Cooperative Groups, NCI To Talk About Overlaps

March 14, 1975